CYFRA 21-1 External Quality Assessment

The RIQAS CYFRA 21-1 EQA programme is designed to cover the analysis of CYFRA 21-1 in clinical laboratories when monitoring the response to treatment of cancers such as non-small cell lung carcinoma, cervical, breast and bladder cancer.

  • Lyophilised samples
  • Monthly reporting
  • Testing covers the full range of clinically relevant decision levels
  • Submit results and view reports online via
  • 12 month subscription

Not accredited to ISO/IEC 17043

[table id=414 datatables_row_details=true datatables_row_details_columns=”F” /]


  • CYFRA 21-1 (Cytokeratin 19)
Clinical Laboratory Survey